# Orion Oyj (ORINF)

> Source: Nexqual · https://nexqual.com/ORINF · data as of 2026-10-22 20:00 UTC · cite as "Nexqual, Orion Oyj (ORINF), nexqual.com/ORINF" · informational, not investment advice.

**Price:** USD 92.05 (+0.00% on the day) · last close of Oct 22, 2026; US market closed, not a live price. Prev close 92.05 · day 96.86–96.86 · 52w 78.95–96.86 · market cap $12.9B · PNK

## Key facts
- Analysts: None.
- Total return with dividends: 1Y +15.7% vs S&P 500 +14.4%; 5Y +148.8% vs S&P 500 +77.0%.
- Next earnings: 2026-10-28, EPS estimate USD —, revenue estimate $538M.

## Analysts
Consensus None.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | +15.7% | +148.8% |
| S&P 500 (SPY) | +14.4% | +77.0% |
| Per year | +15.7% | +20.0% |
| Volatility (annualized) | 12.1% | 28.7% |
| Max drawdown | -2.9% (Oct 2025→Feb 2026) | -20.7% (Apr 2023→Aug 2023) |

## Peers (Drug Manufacturers - General)
GRFS (Grifols, S.A.) USD 7.54 +1.14% · BIIB (Biogen Inc.) USD 250.38 -1.36% · OGN (Organon & Co.) USD 13.75 +0.03% · SNY (Sanofi) USD 41.51 -1.08% · GSK (GSK plc) USD 50.61 -1.17% · BMY (Bristol-Myers Squibb Company) USD 61.53 -2.34%

## More
Full page: https://nexqual.com/ORINF · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | — | — | — | $538.0M | — |
| Next quarter (ends 2026-12-31) | — | — | — | $632.1M | — |
| Current fiscal year (ends 2026-12-31) | — | — | — | $2.10B | — |
| Next fiscal year (ends 2027-12-31) | — | — | — | $2.38B | — |